Whether to maintain or strengthen the treatment for pyoderma gangrenosum ulcerative type may depend on the response after two to four‐week treatment intervention: The outcome of three cases with details clinical course

Abstract

Abstract Determining whether the treatment intensity needs to be increased or can be maintained at a constant level may be suggested after 2–4 weeks of treatment. The use of TNF‐α inhibitor, removal of necrotic tissue, and skin grafting may promote epithelialization.

Keywords

• adalimumab
• adverse effect
• corticosteroid
• pyoderma gangrenosum
• treatment strategy